BIOMAT Database Logo BIOMAT Database Logo

Soluble interleukin-2 receptor levels in pediatric liver transplant recipients. 1993

K L Muth, and T J Schroeder, and F C Ryckman, and L A Martin, and D Traylor, and S H Pedersen, and V S Dittrich, and W F Balistreri
Abbott Diagnostics Clinical Immunology Research Department, North Chicago, Illinois 60064.

UI MeSH Term Description Entries
D008297 Male Males
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D005260 Female Females
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D015375 Receptors, Interleukin-2 Receptors present on activated T-LYMPHOCYTES and B-LYMPHOCYTES that are specific for INTERLEUKIN-2 and play an important role in LYMPHOCYTE ACTIVATION. They are heterotrimeric proteins consisting of the INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT, the INTERLEUKIN-2 RECEPTOR BETA SUBUNIT, and the INTERLEUKIN RECEPTOR COMMON GAMMA-CHAIN. IL-2 Receptors,Interleukin-2 Receptor,Interleukin-2 Receptors,Receptors, IL-2,Receptors, T-Cell Growth Factor,T-Cell Growth Factor Receptors,IL-2 Receptor,IL2 Receptor,IL2 Receptors,Interleukin 2 Receptor,Receptor, TCGF,T-Cell Growth Factor Receptor,TCGF Receptor,TCGF Receptors,IL 2 Receptor,IL 2 Receptors,Interleukin 2 Receptors,Receptor, IL-2,Receptor, IL2,Receptor, Interleukin 2,Receptor, Interleukin-2,Receptors, IL 2,Receptors, IL2,Receptors, Interleukin 2,Receptors, T Cell Growth Factor,Receptors, TCGF,T Cell Growth Factor Receptor,T Cell Growth Factor Receptors
D015415 Biomarkers Measurable and quantifiable biological parameters (e.g., specific enzyme concentration, specific hormone concentration, specific gene phenotype distribution in a population, presence of biological substances) which serve as indices for health- and physiology-related assessments, such as disease risk, psychiatric disorders, ENVIRONMENTAL EXPOSURE and its effects, disease diagnosis; METABOLIC PROCESSES; SUBSTANCE ABUSE; PREGNANCY; cell line development; EPIDEMIOLOGIC STUDIES; etc. Biochemical Markers,Biological Markers,Biomarker,Clinical Markers,Immunologic Markers,Laboratory Markers,Markers, Biochemical,Markers, Biological,Markers, Clinical,Markers, Immunologic,Markers, Laboratory,Markers, Serum,Markers, Surrogate,Markers, Viral,Serum Markers,Surrogate Markers,Viral Markers,Biochemical Marker,Biologic Marker,Biologic Markers,Clinical Marker,Immune Marker,Immune Markers,Immunologic Marker,Laboratory Marker,Marker, Biochemical,Marker, Biological,Marker, Clinical,Marker, Immunologic,Marker, Laboratory,Marker, Serum,Marker, Surrogate,Serum Marker,Surrogate End Point,Surrogate End Points,Surrogate Endpoint,Surrogate Endpoints,Surrogate Marker,Viral Marker,Biological Marker,End Point, Surrogate,End Points, Surrogate,Endpoint, Surrogate,Endpoints, Surrogate,Marker, Biologic,Marker, Immune,Marker, Viral,Markers, Biologic,Markers, Immune
D016019 Survival Analysis A class of statistical procedures for estimating the survival function (function of time, starting with a population 100% well at a given time and providing the percentage of the population still well at later times). The survival analysis is then used for making inferences about the effects of treatments, prognostic factors, exposures, and other covariates on the function. Analysis, Survival,Analyses, Survival,Survival Analyses
D016031 Liver Transplantation The transference of a part of or an entire liver from one human or animal to another. Grafting, Liver,Hepatic Transplantation,Liver Transplant,Transplantation, Hepatic,Transplantation, Liver,Hepatic Transplantations,Liver Grafting,Liver Transplantations,Liver Transplants,Transplant, Liver
D016572 Cyclosporine A cyclic undecapeptide from an extract of soil fungi. It is a powerful immunosupressant with a specific action on T-lymphocytes. It is used for the prophylaxis of graft rejection in organ and tissue transplantation. (From Martindale, The Extra Pharmacopoeia, 30th ed). Cyclosporin A,Ciclosporin,CsA-Neoral,CyA-NOF,Cyclosporin,Cyclosporine A,Neoral,OL 27-400,Sandimmun,Sandimmun Neoral,Sandimmune,CsA Neoral,CsANeoral,CyA NOF,OL 27 400,OL 27400

Related Publications

K L Muth, and T J Schroeder, and F C Ryckman, and L A Martin, and D Traylor, and S H Pedersen, and V S Dittrich, and W F Balistreri
Soluble interleukin-2 receptor in liver transplant recipients.
February 1991, Transplantation proceedings,
K L Muth, and T J Schroeder, and F C Ryckman, and L A Martin, and D Traylor, and S H Pedersen, and V S Dittrich, and W F Balistreri
Systemic (serum) soluble interleukin-2 receptor levels in corneal transplant recipients.
January 1993, Documenta ophthalmologica. Advances in ophthalmology,
K L Muth, and T J Schroeder, and F C Ryckman, and L A Martin, and D Traylor, and S H Pedersen, and V S Dittrich, and W F Balistreri
Soluble interleukin 2 receptor (sIL-2R) levels in renal transplant recipients.
January 2004, Clinical transplantation,
K L Muth, and T J Schroeder, and F C Ryckman, and L A Martin, and D Traylor, and S H Pedersen, and V S Dittrich, and W F Balistreri
Elevated soluble interleukin 2 receptor levels found among kidney transplant recipients.
October 1997, Transplantation,
K L Muth, and T J Schroeder, and F C Ryckman, and L A Martin, and D Traylor, and S H Pedersen, and V S Dittrich, and W F Balistreri
Soluble interleukin-2 receptor in heart transplant recipients.
July 1991, Transplantation,
K L Muth, and T J Schroeder, and F C Ryckman, and L A Martin, and D Traylor, and S H Pedersen, and V S Dittrich, and W F Balistreri
The use of soluble interleukin-2 receptor levels in cardiac transplant recipients.
April 1992, Transplantation,
K L Muth, and T J Schroeder, and F C Ryckman, and L A Martin, and D Traylor, and S H Pedersen, and V S Dittrich, and W F Balistreri
Serum interleukin-2 and soluble interleukin-2 receptor in renal transplant recipients.
September 1992, Journal of the Formosan Medical Association = Taiwan yi zhi,
K L Muth, and T J Schroeder, and F C Ryckman, and L A Martin, and D Traylor, and S H Pedersen, and V S Dittrich, and W F Balistreri
Sequential measurements of soluble interleukin 2 receptor levels in plasma of heart transplant recipients.
August 1990, Transplantation,
K L Muth, and T J Schroeder, and F C Ryckman, and L A Martin, and D Traylor, and S H Pedersen, and V S Dittrich, and W F Balistreri
Soluble interleukin-2 receptors in serum and bile of liver transplant recipients.
March 1989, Lancet (London, England),
K L Muth, and T J Schroeder, and F C Ryckman, and L A Martin, and D Traylor, and S H Pedersen, and V S Dittrich, and W F Balistreri
Soluble CD23 and interleukin-2 receptor levels in renal allograft recipients.
April 1993, Transplantation proceedings,
Copied contents to your clipboard!